Susan B. Nichols is the Chief Business Officer at ViroCell Biologics. With over twenty years of corporate management and leadership experience in high-growth biotech companies, Susan has held global executive management roles in early-stage, emerging, and Fortune 500 companies such as Invetech, Baebies, Thermo Fisher/ASI, Hitachi Chemical, and Roche.

Susan has initiated partnerships with pharmaceutical and life science companies to advance drug development and manufacturing platforms, enabling commercial success while guiding the scaling-up efforts of cell therapies through all phases of clinical trials. In addition, she has supported early-stage life science companies by establishing funding relationships with VC’s, private investment groups, and angel investors, while cementing philanthropic alliances, non-traditional financing, royalty deals, licensing opportunities, and strategic alliances.